Home > Products > CD28 & HN > Recombinant Human Anti-CD28 x Human Anti-HN Bispecific Antibody (scFv-CH1/CL)

Recombinant Human Anti-CD28 x Human Anti-HN Bispecific Antibody (scFv-CH1/CL)  (CAT#: BSCC-H237)

Recombinant Anti-CD28 x Anti-HN Bispecific Antibody (scFv-CH1/CL) is designed to be expressed as two chains. One scFv from an anti-CD28 antibody variable domain is fused to CH1 and the other scFv from an anti-HN antibody variable domain fused to CL, or vice versa. And the CH1 and CL domains are linked covalently via a natural disulfide bond. This BsAb can retarget T cells to tumor cells. It is designed for the tumor vaccine modification and the research of Tumors therapy.
Datasheet INQUIRY

Specifications

Targets
CD28 & HN
Type
scFv-based Bispecific Fragments
Species Reactivity
Human
Application
FuncS; Promising preventive/therapeutic agent
Related Disease
Tumors

Targets

Target 1
CD28
Gene ID
UniProt ID
Alternative Names
CD28; CD28 molecule; Cluster of Differentiation 28; Tp44; T-cell-specific surface glycoprotein CD28; CD28 antigen
Target 2
HN
Gene ID
UniProt ID
Alternative Names
Hemagglutinin-neuraminidase; HN
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "CD28 & HN"
See other bsAb targets related to "CD28"

See other bsAb targets related to "HN"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD28 x Human Anti-HN Bispecific Antibody (scFv-CH1/CL) (BSCC-H237). Click the button below to contact us or submit your feedback about this product.